A Regulatory and Manufacturing Roadmap for Homeopathic Drug Products – Eric L. Foxman R.Ph. ***


A Regulatory and Manufacturing Roadmap for Homeopathic Drug Products
Eric L. Foxman

Recorded Webinar

2.0 hr Pharm (RX) CE (NANCEAC)


The presentation will cover the regulations affecting homeopathic drugs and will examine the role of the Homeopathic Pharmacopeia and the information in this on-line reference. The different manufacturing methods for making homeopathic drug products will be addressed so attendees have an understanding and can make better decisions on what to utilize for patient care. The presentation will include issues to consider for evaluating vendors and supplies for attendees’ practice formularies.


Basic Outline (110 minutes)

Session one

  1. Overview of regulations affecting homeopathic drugs (20 minutes)
  2. Differences between homeopathic products and other CAM productshow these differences affect the attendees’ practice. (10 minutes)
  3. The Homeopathic Pharmacopeia: it’s role and information (25 minutes)

Session two

  1. Manufacturing methods for making homeopathic drug products; impact on labeling information. (30 minutes)
  2. Vendor evaluation and considerations; impact of vendors on attendees practice and formulary. (15 minutes)
  3. Addressing (pre-submitted) questions of interest/concern to attendees (10 minutes)


Learning Objectives

At the conclusion of the presentation the attendee will be able to:

  • Understand the regulatory circumstances under which homeopathic drug products can be made available and the impact some regulations have on the practitioners’ ability to stock, sell and promote those products within their practice.
  • Have a cursory recognition of the importance of the HPUS; this needs to be coupled with sufficient information to know what that importance is based upon and what steps might be necessary in the future to ensure the continued existence of the HPUS as a basis for their use of homeopathic products within their practice.


Skip to content